Yayınlar & Eserler

Yayın Ağı
Makaleler 24
Tümü (24)
SCI-E, SSCI, AHCI (23)
SCI-E, SSCI, AHCI, ESCI (23)
Scopus (24)
TRDizin (3)

1. Relationship Between Ultrasound and Physical Examination in the Assessment of Enthesitis in Patients With Spondyloarthritis: Results From the DEUS Multicenter Study

Di Matteo A., Di Donato S., Smerilli G., Becciolini A., Camarda F., Cauli A., et al.
ARTHRITIS & RHEUMATOLOGY , cilt.77, ss.22-33, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

2. Addressing Glucocorticoid-Related Problems with the Clinical Pharmacist Collaboration in Rheumatology Practice: A Prospective Follow-Up Study

Bahap-Kara M., SARIYILDIZ E., YARDIMCI G. K., KARADAĞ Ö., EKİNCİOĞLU A.
RHEUMATOLOGY AND THERAPY , cilt.11, sa.4, ss.1043-1055, 2024 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

3. Prospective assessment of glucocorticoid toxicity in rheumatology practice: a focus on the glucocorticoid toxicity index

Bahap-Kara M., SARIYILDIZ E., ZENGİN H. Y., KARADAĞ Ö., EKİNCİOĞLU A.
RHEUMATOLOGY , sa.3, ss.1010-1018, 2024 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

4. Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group

Caminati M., Fassio A., Alberici F., Baldini C., Bello F., Cameli P., et al.
Allergy: European Journal of Allergy and Clinical Immunology , cilt.79, sa.2, ss.516-519, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

5. Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates

Sandal Uzun G., Taghiyeva A., Çakır İ. Y., Moral K., YARDIMCI G. K., Bölek E. Ç., et al.
International Journal of Rheumatic Diseases , cilt.27, sa.1, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

6. Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study

Di Matteo A., Smerilli G., Di Donato S., Liu A. R., Becciolini A., Camarda F., et al.
Annals of the Rheumatic Diseases , 2024 (SCI-Expanded, Scopus) identifier identifier identifier

7. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

BİLGİN E., Demirci Yıldırım T., Özdemir Ulusoy B., Öğüt T. S., Karabacak M., Sadioğlu Çağdaş Ö., et al.
Internal and Emergency Medicine , 2024 (SCI-Expanded, Scopus) identifier identifier identifier

8. The predictors of paradoxical reactions, especially psoriasis, to biologic therapy—findings from the TReasure database: a 5-year follow-up study

YAĞIZ B., Lermi N., COŞKUN B. N., DALKILIÇ H. E., KİRAZ S., Erden A., et al.
Rheumatology (United Kingdom) , cilt.62, sa.12, ss.3962-3967, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

9. Comment on: Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis by Humby et al.

Duran E., Yildirim B. E. S., Karadağ Ö.
Clinical and experimental rheumatology , cilt.41, 2023 (SCI-Expanded, Scopus) identifier identifier

10. Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry

Duran E., Ozturk Z. O., BİLGİN E., BÜYÜKAŞIK Y., DİZDAR Ö., Yardimci G. K., et al.
Rheumatology and Therapy , cilt.10, sa.4, ss.969-981, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

11. Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study.

Can Bostan Ö., Duran E., Tuncay G., Cihanbeylerden M., Karadag Ö., Damadoglu E., et al.
The Journal of asthma : official journal of the Association for the Care of Asthma , cilt.60, sa.5, ss.931-937, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

12. Interchangeability and adverse events in originator-rituximab and its biosimilar (CT-P10) among rheumatic patients: a real-life experience

Bahap-Kara M., Duran E., Bayraktar-Ekincioglu A., KARADAĞ Ö.
Internal and Emergency Medicine , cilt.18, sa.3, ss.791-799, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

13. Vital corner of diagnostic challenge: eosinophilic granulomatosis with polyangiitis or COVID-19 pneumonia?

Duran E., Kilic L., Durhan G., Inkaya A. Ç., Guven G. S., Karakaya G., et al.
Annals of the rheumatic diseases , cilt.82, sa.4, 2023 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

14. Comparison of lupus nephritis and non-lupus nephritides in patients with systemic lupus erythematosus

DURAN E., BİLGİN E., KALYONCU U., ERTENLİ A. İ., YILDIRIM T., ARICI M., et al.
Ulusal Romatoloji Dergisi , cilt.15, sa.1, ss.18-24, 2023 (Scopus, TRDizin) Creative Commons License identifier identifier

15. Reliability assessment of the definition of ultrasound enthesitis in SpA: results of a large, multicentre, international, web-based study

Di Matteo A., Cipolletta E., Castaniti G. M. D., Smerilli G., Airoldi C., Aydin S. Z., et al.
RHEUMATOLOGY , cilt.61, ss.4863-4874, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

16. Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience

SARIYILDIZ E., YILDIRIM T., Taghiyeva A., Bilgin E., ARICI M., Saglam E. A., et al.
LUPUS , cilt.31, ss.1147-1156, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

17. Comparison of cardiovascular, cancer and herpes zoster risk of tofacitinib versus etanercept: single-centre observational study

BİLGİN E., SARIYILDIZ E., ÜNALDI E., KALYONCU U., KİRAZ S., Ertenli I.
RHEUMATOLOGY , cilt.61, sa.9, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

18. Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results

AYAN G., Farisogullari B., BİLGİN E., BÖLEK E. Ç., KubraYardimci G., DURAN E., et al.
CLINICAL RHEUMATOLOGY , cilt.41, sa.5, ss.1439-1446, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

19. The clinical features and treatment of eosinophilic granulomatosis with polyangiitis (EGPA) in Turkey: one or two distinct diseases?

DURAN E., CAN BOSTAN Ö., BİLGİN E., KAYA S. B., BÖLEK E. Ç., ÖZER S., et al.
INTERNAL AND EMERGENCY MEDICINE , cilt.17, sa.3, ss.743-751, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

20. Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry.

Farisoğulları B., Yardımcı G. K., Sarı A., Bilgin E., Bölek E. Ç., Duran E., et al.
Clinical and experimental rheumatology , cilt.40, sa.1, ss.112-119, 2022 (SCI-Expanded, Scopus) identifier identifier

21. Cryoglobulinemic vasculitis: having giant steps; but there are still unanswered questions

KARADAĞ Ö., DURAN E.
INTERNAL AND EMERGENCY MEDICINE , cilt.16, sa.1, ss.33-35, 2021 (SCI-Expanded, Scopus) identifier identifier

22. Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience

BİLGİN E., Ceylan F., DURAN E., Farisogullari B., BÖLEK E. Ç., YARDIMCI G. K., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.1, ss.297-308, 2021 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

23. The frequency of Achilles and plantar calcaneal spurs in gout patients

DURAN E., BİLGİN E., ERTENLİ A. İ., KALYONCU U.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.4, ss.1841-1848, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier identifier

24. Frailty prevalence and related factors in the older adult-FrailTURK Project.

Eyigör S., KUTSAL F. Y., Duran E., Huner B., Paker N., Durmus B., et al.
Age (Dordrecht, Netherlands) , cilt.37, sa.3, ss.9791, 2015 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier
Metrikler

Yayın

24

Yayın (WoS)

23

Yayın (Scopus)

24

Atıf (WoS)

45

H-İndeks (WoS)

2

Atıf (Scopus)

101

H-İndeks (Scopus)

5

Atıf (TrDizin)

3

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

3

Proje

1

Açık Erişim

7
BM Sürdürülebilir Kalkınma Amaçları